David W. Dodick, MD
Advertisement
Director, Concussion and Headache Programs, Mayo Clinic; Chair, American Brain Foundation, IHS-Global Patient Advocacy Coalition
Articles by David W. Dodick, MD
Here: highlights from a systematic review that these authors view as a substantial step forward in establishing an evidence-based approach to migraine treatment in the acute care setting.
Advertisement
Latest Updated Articles
Therapies in Development for Acute MigrainePublished: October 30th 2020 | Updated:
Gepants for Acute Migraine: Safety & Efficacy DataPublished: October 30th 2020 | Updated:
Treating Acute Migraine in the Community SettingPublished: October 30th 2020 | Updated:
Advances in the Treatment of Acute MigrainePublished: October 30th 2020 | Updated:
Real-World Experience With Gepants for Acute MigrainePublished: October 30th 2020 | Updated:
Ubrogepant: Treatment for Acute MigrainePublished: October 30th 2020 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Action Update, October 2025: Clearance, Acceptance, and Extension
2
Caregiver Decision-Making for Duchenne Gene Therapy Use Requires Collaborative Input, Thoughtful Consideration
3
Study Shows Caregivers Willing to Discuss Social Determinants of Health in Pediatric Multidisciplinary Clinics
4
Mechanistic Rationale for Factor XIa Inhibition
5
